Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 6/2013

01.08.2013 | Original Paper

Additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention

verfasst von: Voin Brkovic, Milan Dobric, Branko Beleslin, Vojislav Giga, Vladan Vukcevic, Sinisa Stojkovic, Goran Stankovic, Milan A. Nedeljkovic, Dejan Orlic, Miloje Tomasevic, Jelena Stepanovic, Miodrag Ostojic

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

This study evaluated additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI). All six scores were calculated in 209 consecutive STEMI patients undergoing pPCI. Primary end-point was the major adverse cardiovascular event (MACE—composite of cardiovascular mortality, non-fatal myocardial infarction and stroke); secondary end point was cardiovascular mortality. Patients were stratified according to the SYNTAX score tertiles (≤12; between 12 and 19.5; >19.5). The median follow-up was 20 months. Rates of MACE and cardiovascular mortality were highest in the upper tertile of the SYNTAX score (p < 0.001 and p = 0.003, respectively). SYNTAX score was independent multivariable predictor of MACE and cardiovascular mortality when added to GRACE, TIMI, ZWOLLE, and PAMI risk scores. However, the SYNTAX score did not improve the Cox regression models of MACE and cardiovascular mortality when added to the CADILLAC score. The SYNTAX score has predictive value for MACE and cardiovascular mortality in patients with STEMI undergoing primary PCI. Furthermore, SYNTAX score improves prognostic performance of well-established GRACE, TIMI, ZWOLLE and PAMI clinical scores, but not the CADILLAC risk score. Therefore, long-term survival in patients after STEMI depends less on detailed angiographical characterization of coronary lesions, but more on clinical characteristics, myocardial function and basic angiographic findings as provided by the CADILLAC score.
Literatur
1.
Zurück zum Zitat Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The syntax score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1:219–227PubMed Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The syntax score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1:219–227PubMed
2.
Zurück zum Zitat Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, Van Dyck N, Mack M, Holmes D, Feldman T, Morice MC, Colombo A, Bass E, Leadley K, Dawkins KD, van Es GA, Morel MA, Mohr FW (2009) Assessment of the syntax score in the syntax study. EuroIntervention 5:50–56PubMedCrossRef Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, Van Dyck N, Mack M, Holmes D, Feldman T, Morice MC, Colombo A, Bass E, Leadley K, Dawkins KD, van Es GA, Morel MA, Mohr FW (2009) Assessment of the syntax score in the syntax study. EuroIntervention 5:50–56PubMedCrossRef
3.
Zurück zum Zitat Garg S, Girasis C, Sarno G, Goedhart D, Morel MA, Garcia–Garcia HM, Bressers M, van Es GA, Serruys PW (2010) The syntax score revisited: a reassessment of the syntax score reproducibility. Catheter Cardiovasc Interv 75:946–952PubMed Garg S, Girasis C, Sarno G, Goedhart D, Morel MA, Garcia–Garcia HM, Bressers M, van Es GA, Serruys PW (2010) The syntax score revisited: a reassessment of the syntax score reproducibility. Catheter Cardiovasc Interv 75:946–952PubMed
4.
Zurück zum Zitat Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360:961–972PubMedCrossRef Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360:961–972PubMedCrossRef
5.
Zurück zum Zitat Kappetein AP, Feldman TE, Mack MJ, Morice MC, Holmes DR, Stahle E, Dawkins KD, Mohr FW, Serruys PW, Colombo A (2011) Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the syntax trial. Eur Heart J 32:2125–2134PubMedCrossRef Kappetein AP, Feldman TE, Mack MJ, Morice MC, Holmes DR, Stahle E, Dawkins KD, Mohr FW, Serruys PW, Colombo A (2011) Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the syntax trial. Eur Heart J 32:2125–2134PubMedCrossRef
6.
Zurück zum Zitat Holmes DR, Vazales B, Cannon LA, Stahle E, Morice MC, Mack MJ, Feldman TE, Kappetein AP, Colombo A, Dawkins KD, Mohr FW, Serruys PW (2011) Tct-228: four year follow-up of the syntax trial: optimal revascularization strategy in patients with three-vessel disease and/or left main disease. J Am Coll Cardiol 58:B61 Holmes DR, Vazales B, Cannon LA, Stahle E, Morice MC, Mack MJ, Feldman TE, Kappetein AP, Colombo A, Dawkins KD, Mohr FW, Serruys PW (2011) Tct-228: four year follow-up of the syntax trial: optimal revascularization strategy in patients with three-vessel disease and/or left main disease. J Am Coll Cardiol 58:B61
7.
Zurück zum Zitat Mohr FW, Morice MC, Kappetein AP, Feldman TE, Stahle E, Mack MJ, Colombo A, Holmes DR, Dawkins KD, Serruys PW (2012) Final five-year follow-up of the syntax trial: optimal revascularisation strategy in patients with three-vessel disease and/or left main disease (abstract 2992). Eur Heart J 33:500 Mohr FW, Morice MC, Kappetein AP, Feldman TE, Stahle E, Mack MJ, Colombo A, Holmes DR, Dawkins KD, Serruys PW (2012) Final five-year follow-up of the syntax trial: optimal revascularisation strategy in patients with three-vessel disease and/or left main disease (abstract 2992). Eur Heart J 33:500
8.
Zurück zum Zitat Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Rademaker T, Wittebols K, Stoll HP (2010) 5-year clinical outcomes of the arts II (arterial revascularization therapies study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 55:1093–1101PubMedCrossRef Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Rademaker T, Wittebols K, Stoll HP (2010) 5-year clinical outcomes of the arts II (arterial revascularization therapies study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 55:1093–1101PubMedCrossRef
9.
Zurück zum Zitat Valgimigli M, Serruys PW, Tsuchida K, Vaina S, Morel MA, van den Brand MJ, Colombo A, Morice MC, Dawkins K, de Bruyne B, Kornowski R, de Servi S, Guagliumi G, Jukema JW, Mohr FW, Kappetein AP, Wittebols K, Stoll HP, Boersma E, Parrinello G (2007) Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 99:1072–1081PubMedCrossRef Valgimigli M, Serruys PW, Tsuchida K, Vaina S, Morel MA, van den Brand MJ, Colombo A, Morice MC, Dawkins K, de Bruyne B, Kornowski R, de Servi S, Guagliumi G, Jukema JW, Mohr FW, Kappetein AP, Wittebols K, Stoll HP, Boersma E, Parrinello G (2007) Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 99:1072–1081PubMedCrossRef
10.
Zurück zum Zitat Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C (2009) Usefulness of the syntax score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv 2:302–308PubMedCrossRef Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C (2009) Usefulness of the syntax score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv 2:302–308PubMedCrossRef
11.
Zurück zum Zitat Capodanno D, Capranzano P, Di Salvo ME, Caggegi A, Tomasello D, Cincotta G, Miano M, Patane M, Tamburino C, Tolaro S, Patane L, Calafiore AM (2009) Usefulness of syntax score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft. JACC Cardiovasc Interv 2:731–738PubMedCrossRef Capodanno D, Capranzano P, Di Salvo ME, Caggegi A, Tomasello D, Cincotta G, Miano M, Patane M, Tamburino C, Tolaro S, Patane L, Calafiore AM (2009) Usefulness of syntax score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft. JACC Cardiovasc Interv 2:731–738PubMedCrossRef
12.
Zurück zum Zitat Onuma Y, Girasis C, Piazza N, Garcia–Garcia HM, Kukreja N, Garg S, Eindhoven J, Cheng JM, Valgimigli M, van Domburg R, Serruys PW (2010) Long-term clinical results following stenting of the left main stem: insights from research (rapamycin-eluting stent evaluated at rotterdam cardiology hospital) and t-search (taxus-stent evaluated at rotterdam cardiology hospital) registries. JACC Cardiovasc Interv 3:584–594PubMedCrossRef Onuma Y, Girasis C, Piazza N, Garcia–Garcia HM, Kukreja N, Garg S, Eindhoven J, Cheng JM, Valgimigli M, van Domburg R, Serruys PW (2010) Long-term clinical results following stenting of the left main stem: insights from research (rapamycin-eluting stent evaluated at rotterdam cardiology hospital) and t-search (taxus-stent evaluated at rotterdam cardiology hospital) registries. JACC Cardiovasc Interv 3:584–594PubMedCrossRef
13.
Zurück zum Zitat Wykrzykowska JJ, Garg S, Girasis C, de Vries T, Morel MA, van Es GA, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, di Mario C, van Geuns RJ, Juni P, Windecker S, Serruys PW (2010) Value of the syntax score for risk assessment in the all-comers population of the randomized multicenter leaders (limus eluted from a durable versus erodable stent coating) trial. J Am Coll Cardiol 56:272–277PubMedCrossRef Wykrzykowska JJ, Garg S, Girasis C, de Vries T, Morel MA, van Es GA, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, di Mario C, van Geuns RJ, Juni P, Windecker S, Serruys PW (2010) Value of the syntax score for risk assessment in the all-comers population of the randomized multicenter leaders (limus eluted from a durable versus erodable stent coating) trial. J Am Coll Cardiol 56:272–277PubMedCrossRef
14.
Zurück zum Zitat Lemesle G, Bonello L, de Labriolle A, Steinberg DH, Roy P, Pinto Slottow TL, Torguson R, Kaneshige K, Xue Z, Suddath WO, Satler LF, Kent KM, Lindsay J, Pichard AD, Waksman R (2009) Prognostic value of the syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease. Catheter Cardiovasc Interv 73:612–617PubMedCrossRef Lemesle G, Bonello L, de Labriolle A, Steinberg DH, Roy P, Pinto Slottow TL, Torguson R, Kaneshige K, Xue Z, Suddath WO, Satler LF, Kent KM, Lindsay J, Pichard AD, Waksman R (2009) Prognostic value of the syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease. Catheter Cardiovasc Interv 73:612–617PubMedCrossRef
15.
Zurück zum Zitat Magro M, Nauta S, Simsek C, Onuma Y, Garg S, van der Heide E, van der Giessen WJ, Boersma E, van Domburg RT, van Geuns RJ, Serruys PW (2011) Value of the syntax score in patients treated by primary percutaneous coronary intervention for acute st-elevation myocardial infarction: the MI SYNTAXscore study. Am Heart J 161:771–781PubMedCrossRef Magro M, Nauta S, Simsek C, Onuma Y, Garg S, van der Heide E, van der Giessen WJ, Boersma E, van Domburg RT, van Geuns RJ, Serruys PW (2011) Value of the syntax score in patients treated by primary percutaneous coronary intervention for acute st-elevation myocardial infarction: the MI SYNTAXscore study. Am Heart J 161:771–781PubMedCrossRef
16.
Zurück zum Zitat Scherff F, Vassalli G, Surder D, Mantovani A, Corbacelli C, Pasotti E, Klersy C, Auricchio A, Moccetti T, Pedrazzini GB (2011) The syntax score predicts early mortality risk in the elderly with acute coronary syndrome having primary PCI. J Invasive Cardiol 23:505–510PubMed Scherff F, Vassalli G, Surder D, Mantovani A, Corbacelli C, Pasotti E, Klersy C, Auricchio A, Moccetti T, Pedrazzini GB (2011) The syntax score predicts early mortality risk in the elderly with acute coronary syndrome having primary PCI. J Invasive Cardiol 23:505–510PubMed
17.
Zurück zum Zitat Magro M, Nauta ST, Simsek C, Boersma E, van der Heide E, Regar E, van Domburg RT, Zijlstra F, Serruys PW, van Geuns RJ (2012) Usefulness of the syntax score to predict “no reflow” in patients treated with primary percutaneous coronary intervention for st-segment elevation myocardial infarction. Am J Cardiol 109:601–606PubMedCrossRef Magro M, Nauta ST, Simsek C, Boersma E, van der Heide E, Regar E, van Domburg RT, Zijlstra F, Serruys PW, van Geuns RJ (2012) Usefulness of the syntax score to predict “no reflow” in patients treated with primary percutaneous coronary intervention for st-segment elevation myocardial infarction. Am J Cardiol 109:601–606PubMedCrossRef
18.
Zurück zum Zitat Garg S, Sarno G, Serruys PW, Rodriguez AE, Bolognese L, Anselmi M, De Cesare N, Colangelo S, Moreno R, Gambetti S, Monti M, Bristot L, Bressers M, Garcia–Garcia HM, Parrinello G, Campo G, Valgimigli M (2011) Prediction of 1-year clinical outcomes using the syntax score in patients with acute st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the strategy (single high-dose bolus tirofiban and sirolimus-eluting stent versus abciximab and bare-metal stent in acute myocardial infarction) and multistrategy (multicenter evaluation of single high-dose bolus tirofiban versus abciximab with sirolimus-eluting stent or bare-metal stent in acute myocardial infarction study) trials. JACC Cardiovasc Interv 4:66–75PubMedCrossRef Garg S, Sarno G, Serruys PW, Rodriguez AE, Bolognese L, Anselmi M, De Cesare N, Colangelo S, Moreno R, Gambetti S, Monti M, Bristot L, Bressers M, Garcia–Garcia HM, Parrinello G, Campo G, Valgimigli M (2011) Prediction of 1-year clinical outcomes using the syntax score in patients with acute st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the strategy (single high-dose bolus tirofiban and sirolimus-eluting stent versus abciximab and bare-metal stent in acute myocardial infarction) and multistrategy (multicenter evaluation of single high-dose bolus tirofiban versus abciximab with sirolimus-eluting stent or bare-metal stent in acute myocardial infarction study) trials. JACC Cardiovasc Interv 4:66–75PubMedCrossRef
19.
Zurück zum Zitat Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA (2003) Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163:2345–2353PubMedCrossRef Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA (2003) Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163:2345–2353PubMedCrossRef
20.
Zurück zum Zitat Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E (2000) Timi risk score for st-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous npa for treatment of infarcting myocardium early ii trial substudy. Circulation 102:2031–2037PubMedCrossRef Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E (2000) Timi risk score for st-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous npa for treatment of infarcting myocardium early ii trial substudy. Circulation 102:2031–2037PubMedCrossRef
21.
Zurück zum Zitat De Luca G, Suryapranata H, van’t Hof AW, de Boer MJ, Hoorntje JC, Dambrink JH, Gosselink AT, Ottervanger JP, Zijlstra F (2004) Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 109:2737–2743PubMedCrossRef De Luca G, Suryapranata H, van’t Hof AW, de Boer MJ, Hoorntje JC, Dambrink JH, Gosselink AT, Ottervanger JP, Zijlstra F (2004) Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 109:2737–2743PubMedCrossRef
22.
Zurück zum Zitat Halkin A, Singh M, Nikolsky E, Grines CL, Tcheng JE, Garcia E, Cox DA, Turco M, Stuckey TD, Na Y, Lansky AJ, Gersh BJ, O’Neill WW, Mehran R, Stone GW (2005) Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 45:1397–1405PubMedCrossRef Halkin A, Singh M, Nikolsky E, Grines CL, Tcheng JE, Garcia E, Cox DA, Turco M, Stuckey TD, Na Y, Lansky AJ, Gersh BJ, O’Neill WW, Mehran R, Stone GW (2005) Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 45:1397–1405PubMedCrossRef
23.
Zurück zum Zitat Addala S, Grines CL, Dixon SR, Stone GW, Boura JA, Ochoa AB, Pellizzon G, O’Neill WW, Kahn JK (2004) Predicting mortality in patients with st-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol 93:629–632PubMedCrossRef Addala S, Grines CL, Dixon SR, Stone GW, Boura JA, Ochoa AB, Pellizzon G, O’Neill WW, Kahn JK (2004) Predicting mortality in patients with st-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). Am J Cardiol 93:629–632PubMedCrossRef
24.
Zurück zum Zitat The InTIME-II Investigators (2000) Intravenous npa for the treatment of infarcting myocardium early; intime-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J 21:2005–2013 The InTIME-II Investigators (2000) Intravenous npa for the treatment of infarcting myocardium early; intime-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J 21:2005–2013
25.
Zurück zum Zitat The TIMI Study Group (1985) The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. Timi study group. N Engl J Med 312:932–936 The TIMI Study Group (1985) The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. Timi study group. N Engl J Med 312:932–936
26.
Zurück zum Zitat Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American society of echocardiography’s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 18:1440–1463CrossRef Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American society of echocardiography’s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 18:1440–1463CrossRef
27.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef
28.
Zurück zum Zitat Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36PubMed Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36PubMed
29.
Zurück zum Zitat Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R, Dangas G, Lazar D, Sanchez R, Fahy M, Xu K, Stone GW (2011) Prognostic value of the syntax score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the acuity (acute catheterization and urgent intervention triage strategy) trial. J Am Coll Cardiol 57:2389–2397PubMedCrossRef Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R, Dangas G, Lazar D, Sanchez R, Fahy M, Xu K, Stone GW (2011) Prognostic value of the syntax score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the acuity (acute catheterization and urgent intervention triage strategy) trial. J Am Coll Cardiol 57:2389–2397PubMedCrossRef
30.
Zurück zum Zitat Genereux P, Palmerini T, Caixeta A, Cristea E, Mehran R, Sanchez R, Lazar D, Jankovic I, Corral MD, Dressler O, Fahy MP, Parise H, Lansky AJ, Stone GW (2011) Syntax score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ Cardiovasc Interv 4:553–561PubMedCrossRef Genereux P, Palmerini T, Caixeta A, Cristea E, Mehran R, Sanchez R, Lazar D, Jankovic I, Corral MD, Dressler O, Fahy MP, Parise H, Lansky AJ, Stone GW (2011) Syntax score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ Cardiovasc Interv 4:553–561PubMedCrossRef
31.
Zurück zum Zitat Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Lansky AJ (2002) Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346:957–966PubMedCrossRef Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Lansky AJ (2002) Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346:957–966PubMedCrossRef
32.
Zurück zum Zitat Thygesen K, Alpert JS, White HD (2007) Universal definition of myocardial infarction. Eur Heart J 28:2525–2538PubMedCrossRef Thygesen K, Alpert JS, White HD (2007) Universal definition of myocardial infarction. Eur Heart J 28:2525–2538PubMedCrossRef
33.
Zurück zum Zitat Soreide K (2009) Sensitivity and specificity in diagnostic accuracy: ROC solid or lost in translation? J Clin Pathol 62:1051–1052PubMedCrossRef Soreide K (2009) Sensitivity and specificity in diagnostic accuracy: ROC solid or lost in translation? J Clin Pathol 62:1051–1052PubMedCrossRef
Metadaten
Titel
Additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention
verfasst von
Voin Brkovic
Milan Dobric
Branko Beleslin
Vojislav Giga
Vladan Vukcevic
Sinisa Stojkovic
Goran Stankovic
Milan A. Nedeljkovic
Dejan Orlic
Miloje Tomasevic
Jelena Stepanovic
Miodrag Ostojic
Publikationsdatum
01.08.2013
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 6/2013
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-013-0202-1

Weitere Artikel der Ausgabe 6/2013

The International Journal of Cardiovascular Imaging 6/2013 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.